FTC prods Merck & Co and Schering-Plough for more merger details
This article was originally published in Scrip
Executive Summary
The US government has requested more information regarding Schering-Plough's and Merck & Co's proposed $41.1 billion merger. The Federal Trade Commission's antitrust review is its second query into the deal that would create the world's second largest pharmaceutical company.